Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
112.05
75.65
93.56
101.79
115.98
84.41
93.23
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
112.05
75.65
93.56
101.79
115.98
84.41
93.23
Raw Material Cost
0.00
39.45
41.34
41.23
44.85
35.88
41.07
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.78
1.60
0.00
0.72
0.52
1.34
Selling and Distribution Expenses
0.00
27.19
27.59
42.97
40.18
36.11
29.19
Other Expenses
0.00
0.73
0.96
1.02
1.01
0.89
0.91
Total Expenditure (Excl Depreciation)
0.00
74.68
80.12
94.40
95.82
81.40
80.74
Operating Profit (PBDIT) excl Other Income
112
1
13.4
7.4
20.2
3
12.5
Other Income
0.00
1.80
0.14
-0.26
-0.24
1.32
0.35
Operating Profit (PBDIT)
0.00
20.36
26.69
21.34
32.80
17.23
25.07
Interest
0.00
0.78
1.60
0.00
0.72
0.52
1.34
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.65
Gross Profit (PBDT)
0.00
36.20
52.22
60.57
71.13
48.53
52.16
Depreciation
0.00
17.59
14.20
14.20
12.89
12.89
12.22
Profit Before Tax
10.28
1.99
10.88
7.14
19.19
3.82
12.16
Tax
0.00
0.35
0.64
0.56
3.02
0.01
3.46
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10.53
1.64
10.24
6.58
16.17
3.81
8.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10.53
1.64
10.24
6.58
16.17
3.81
8.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10.53
1.64
10.24
6.58
16.17
3.81
8.70
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
814.32
814.83
812.14
806.03
794.90
818.07
810.73
Earnings per share (EPS)
0.16
0.03
0.15
0.11
0.26
0.06
0.14
Diluted Earnings per share
0.16
0.03
0.15
0.11
0.26
0.06
0.14
Operating Profit Margin (Excl OI)
0.0%
1.28%
13.2%
7.26%
17.38%
3.57%
13.4%
Gross Profit Margin
9.18%
25.88%
26.81%
20.96%
27.66%
19.79%
26.15%
PAT Margin
9.4%
2.17%
10.95%
6.47%
13.94%
4.51%
9.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -3.45% vs 6.91% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -35.19% vs 1.25% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -100.00% vs 14.19% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -100.00% vs -12.50% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of HOB Biotech Group Corp. Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
112.05
0
112.05
Other Operating Income
0.00
0.00
0.00
Total Operating income
112.05
0
112.05
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
0.00
0
0.00
Operating Profit (PBDIT) excl Other Income
112.05
0.00
112.05
Other Income
0.00
0
0.00
Operating Profit (PBDIT)
0.00
0
0.00
Interest
0.00
0
0.00
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
0.00
0
0.00
Depreciation
0.00
0
0.00
Profit Before Tax
10.28
0
10.28
Tax
0.00
0
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
10.53
0
10.53
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
10.53
0
10.53
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10.53
0
10.53
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
814.32
0
814.32
Earnings per share (EPS)
0.16
0
0.16
Diluted Earnings per share
0.16
0
0.16
Operating Profit Margin (Excl OI)
0.00%
0%
0.00
0.00%
Gross Profit Margin
9.18%
0%
0.00
9.18%
PAT Margin
9.40%
0%
0.00
9.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 11.20 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 48.15% vs -19.23% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -3.45% vs 6.91% in Jun 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.05 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 556.25% vs -84.31% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -35.19% vs 1.25% in Jun 2024
Quarterly - Operating Profit (PBDIT)
No Operating Profit (PBDIT) in the last few periods
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
No Operating Profit Margin (Excl OI) in the last few periods






